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Some cruciferous plants may serve as preventive treatments for several medical conditions; our objective was to systematically in-
vestigate their safety in humans. Four electronic databases were searched, and, of 10,831 references identiﬁed, 50 were included.
Data were extracted by two independent reviewers, whereafter the association between interventions and adverse events was asses-
sed. Adverse events in 53 subjects were identiﬁed through clinical trials; of these, altered drug metabolism was rated as certainly/
likely caused by cruciferous plants. Adverse events in 1247 subjects were identiﬁed through observational studies, of which none
received high causality ratings. Adverse events in 35 subjects were identiﬁed through case reports, of which allergies and warfarin
resistance were rated as certainly/likely caused by cruciferous plants. We conclude that cruciferous plants are safe in humans, with
the exception of allergies. Individuals treated with warfarin should consult their physician. Further investigation of uses of cruci-
ferous plants in preventative medicine is warranted.
1.Introduction
In the last decade, a rapid rise in the demand for natural
health products has become evident. This prominent trend
stems from increasing awareness of the potential for signiﬁ-
cant adverse eﬀects caused by pharmacologic interventions,
along with a growing interest in preventive medicine strate-
gies [1].
A group of plants that has been shown to possess strong
anti-inﬂammatory and antioxidative abilities is the crucif-
erous plants of the Brassica genus. Brassica is a genus of
plants in the Brassicaceae family. Vegetables of the family
Brassicaceae (also called Cruciferae) are generally referred to
as cruciferous vegetables. These vegetables are widely culti-
vated, with many genera, species, and cultivars being raised
for food production. The most common Brassica vegetables
eaten by people are in a single species (B. oleracea), including
kale, collard greens, cabbage, Brussels sprouts, kohlrabi,
broccoli, and cauliﬂower. Numerous other species in the
genusarealsoediblesuchasmustard(B.nigra),Chinesecab-
bage (B. rapa), and oilseed rape (B. napus; sometimes re-
ferred to as “rapeseed oil” or “canola”) [2].
Some members of this group have received wide acclaim
as potential natural preventers or attenuators of several
health conditions such as coronary artery disease, gastritis,
andcancer[3–8].Recentstudiesrevealthatthesetherapeutic
eﬀects may extend to the fetus as well: an international case-
control study showed that maternal consumption of cru-
ciferous vegetables during pregnancy decreases the risk of
childhood anaplastic astrocarcinomas [9] ;as t u d yi nr a t s
found that oﬀspring of spontaneously hypertensive rats that
consumed broccoli sprouts during gestation had lower blood
pressure and reduced markers of oxidative stress and inﬂam-
mation, compared to controls [10].
The impetus for this systematic review stems from work
done in our laboratory that has shown the potential beneﬁt
of supplementing the diet of pregnant dams with broccoli
sprouts in preventing perinatal brain injury. In this regard,2 Journal of Biomedicine and Biotechnology
Table 1: Eligibility criteria and data extracted1.
PICOS Eligibility criteria Data extracted
Patient All human subjects were included
Age, concurrent medical conditions and
treatments, reason for intervention (where
relevant)
Intervention
All types of exposure (oral, topical, or respiratory)
to cruciferous plants, their derivatives, or their
constituents
Plant or substance exposed to, route of exposure,
duration of exposure, dose (if available)
Comparators
Reports with or without a comparator group.
Reports without control groups were included in
order to include all potential adverse events
Numbers in the intervention and comparator
groups (when relevant)
Outcome Reports of presence or absence of adverse events
Presence or absence of adverse events, description
of adverse event, acute management of adverse
event (for case reports), outcome (when
available), and causality
Study design
All study designs which were relevant to the
assessment of safety were included. Studies in all
languages were included and translated when
necessary
Type of study design and setting
1PICOS: patient, intervention, comparators, outcome, study design.
we have established a model of chronic placental insuﬃ-
ciency that results in fetal growth restriction and damage to
the white matter of the brain, reminiscent of periventricular
leukomalacia, the anatomic hallmark of cerebral palsy. Sup-
plementing the maternal diet during the last trimester of
pregnancy and ﬁrst weeks of infant nutrition prevented
the white matter injury and accompanying behavioural
deﬁcits in the oﬀspring. These ﬁndings suggest, for the ﬁrst
time, a safe and eﬃcacious approach to the prevention of
developmental disability and cerebral palsy [11]. In order to
provide the background in which to determine whether this
therapy would be acceptable for humans, a thorough deter-
mination of the safety of the cruciferous species of plants in
humans is necessary.
Researchers now believe that the key to the therapeutic
abilities of cruciferous plants is their high content of phase-
2 enzyme inducers such as sulforaphane, which induce the
transcriptionofgenesfoundunderthecontroloftheantioxi-
dantresponseelement(ARE).Thiscausesanupregulationof
the endogenous antioxidant glutathione, crucial to the cell’s
ability to withstand oxidative stress [12–14].
Several reviews evaluated the safety and health beneﬁts
of some components of cruciferous plants, such as indole-
3-carbinol and isothiocyanates, and found them safe for
humans [15, 16]. However, to our knowledge, a systematic
review evaluating the safety of cruciferous plants, namely,
the degree of certainty that they would not cause any adverse
eﬀects, has not yet been published.
The purpose of this paper is to systematically collect and
synthesize all published reports of human adverse events
associated with exposure to cruciferous plants. This appro-
ach of analyzing safety of a multi-ingredient natural product
isespeciallyimportantwhenconsideringconsumptionofthe
whole plant as a therapeutic means, as opposed to treatment
with an isolated component or metabolite of a plant.
2. Methods
This systematic paper was undertaken in line with the rele-
vant criteria of the PRISMA (Preferred Reporting Items for
Systematic Reviews and Meta-Analyses) statement [17]. The
following methods used in the systematic review, including
identiﬁcation, screening, eligibility criteria, inclusion, and
data extraction, were agreed upon by the authors ap r i o r i .
Referenceswereidentiﬁedthroughcomprehensivesearch
strategies, which were developed in conjunction with a re-
search librarian. An electronic search of the following four
databases was performed: Medline, Embase, Pascal, and IPA
(International Pharmaceutical Abstracts), from inception to
July 2010, irrespective of language. The following search
termswereused:isothiocyanate,Brassica,cruciferous,gluco-
raphanin, sulforaphane, broccoli, kale, cabbage, cauliﬂower,
collardgreen,Brusselssprout.MESHheadingsandkeywords
were searched, and truncation was used as needed. A list
of the search strategies is available as supplemental material
available online at doi: 10.1155/2012/503241.
The research question and eligibility criteria were devel-
oped by using PICOS (patient, intervention, comparators,
outcome,studydesign).Theinclusioncriteriawereanystud-
ies reporting original data, addressing safety of cruciferous
plants, their derivatives, or their constituents, to humans.
Details of the eligibility criteria are reported in Table 1.
The references were imported into a bibliographic data-
base (RefWorks). Titles and abstracts of identiﬁed studies
were independently screened by two reviewers. Full texts for
potentially relevant studies were obtained and reviewed for
inclusionbasedonpredeterminedcriteria.Disagreementwas
resolvedbyconsensus,andifnecessaryathirdpartywascon-
sulted (JYY).
Data was extracted by two independent reviewers, using
standardized forms. Disagreement was resolved by consen-
sus. Data relating to the patient or group, the intervention,Journal of Biomedicine and Biotechnology 3
the comparator group (where relevant), the outcomes mea-
sured (adverse events or lack thereof), and the study design
were extracted as detailed in Table 1.
The degree of association between the intervention and
the adverse event was independently assessed by the two
reviewers using the Causality Algorithm used by Health
Canada and the WHO Collaborating Centre for Interna-
tional Drug Monitoring (Health Canada 2009). Categories
for assessment were certainly, likely, possibly, unlikely, con-
ditional/unclassiﬁed, and Unassessible/Unclassiﬁable. Dis-
agreement between reviewers was resolved by discussion.
Guidelines used to assess causality are available as supple-
mental material.
The studies were ﬁnally categorized into 3 groups: (1)
trials, (2) observational studies, and (3) case reports. Studies
were classiﬁed as controlled clinical trials when involving
one or more test treatments, at least one control treatment,
speciﬁed outcome measures for evaluating the studied inter-
vention, and when the method for assigning patients to
the test treatment was not a mathematical randomization
technique. Randomized controlled trials, on the other hand,
weredeﬁnedasstudiesinwhichrandomizationusingmathe-
matical techniques, such as the use of a random numbers
table, is employed to assign patients to test or control treat-
ments. Studies were classiﬁed as single-case experimental
design trials when the subjects served as his/her own control,
rather than using another individual or a group.
We did not perform a meta-analysis as the inclusion cri-
teria for subjects, interventions, clinical outcomes, and study
designswereveryheterogeneous;conductingameta-analysis
using these data would not have been appropriate.
3. Results
3.1. Study Characteristics. Searches resulted in a total of
10,831 references. After screening of titles and abstracts, the
full texts of 367 articles were obtained. Of these, 50 articles
met all inclusion criteria. Of the total included publications,
45 were published in English, 2 were published in German,
and one each was published in Italian, French, and Spanish.
Articles were excluded for the following reasons: not
human subjects (210), not evaluating adverse eﬀects or lack
thereof (21), intervention or substance exposure does not
include cruciferous plants (2), not presenting original data
(47). Thirty-seven articles discussing toxic oil syndrome (37)
were excluded post hoc for reasons presented below.
Of the 50 included studies, 13 were trials (6 single-case
experimental design trials, 4 controlled clinical trials, and
3 randomized control trials (RCTs)), 13 were observational
studies (7 cohort studies, 3 case-control studies, 2 cross-sec-
tional studies, and 1 qualitative survey), and 24 were case re-
ports (Figure 1).
3.2. Trials. Thirteen trials were included, reporting adverse
events in 53/496 patients (10.7%) [18–30]. Three of them
were randomized controlled trials (RCTs), 4 were controlled
clinical trials, and 6 were single-case experimental design
(SCED) trials. Six of the trials were classiﬁed as safety trials,
meaning that their stated primary aim was to assess safety of
interventions [18–23], whereas 7 were nonsafety trials which
evaluated eﬃcacy of interventions but also reported adverse
events [24–30]( Table 2).
Thesafetytrials[18–23]included1RCT,1controlledcli-
nical trial, and 4 SCED trials. The only safety RCT was a
double-blinded trial in 12 healthy subjects, ages 28–57, of
whom 9 consumed daily doses of broccoli sprout extract
combined with myrosinase (an enzyme found in all Brassica
which converts glucosinolates to active isothiocyanates) over
a period of 7 days. Extracts contained 25µmol glucosinolate,
100µmol glucosinolate, or 25µmol isothiocyanate. No ad-
verse events were reported [18].
The second safety trial was a double-blind controlled cli-
nical trial in 76 subjects, ages 3–39. Thirty-eight subjects had
a reported mustard allergy, and 38 age- and gender-matched
controls suﬀered from dust-mite allergy but had no mus-
tard allergy. Both groups underwent food challenges with
mustard and a variety of other allergens. Of the 38 patients,
14 had a positive mustard challenge, of which 12 had oral
allergysyndrome(pruritus,mildangioedemaoflips,tongue,
and throat), 1 had more severe angioedema with bronchial
asthma, and 1 had systemic anaphylaxis. It is important to
mention that of the 38 patients, 35 were atopic (including
rhinitis, and/or bronchial asthma, atopic dermatitis) [19].
The last four safety trials were all single-case experimen-
tal design trials (SCED). The ﬁrst was a trial in 10 healthy
subjects, ages 21–30, which strived to determine the eﬀect of
cruciferous vegetables on phenacetin and antipyrine meta-
bolism. Subjects started by consuming a control diet for
13 days, after which they were placed on a diet containing
300g/day of Brussels sprouts and 200g/day of cabbage over a
period of 7 days, and ﬁnally returned to the control diet for
the last 10 days. In parallel, every morning the subjects were
giveneither900mgofphenacetinor1.8mg/kgofantipyrine.
The mean plasma concentrations of either drug were mea-
sured at diﬀerent intervals after administration. Researchers
found that the cruciferous diet enhanced the phenacetin
metabolism in the gastrointestinal tract and/or during its
ﬁrst pass in the liver, increasing its rate of elimination. No
changes in antipyrine metabolism were noted [20]. It is
worth noting that the US Food and Drug Administration
ordered the withdrawal of drugs containing phenacetin in
November1983,owingtoitscarcinogenicandkidney-dama-
ging properties (Federal Register of October 5, 1983 (48 FR
45466)).
The second SCED trial included 10 healthy subjects, ages
23–35, and aimed to determine the eﬀect of cruciferous veg-
etables on acetaminophen and oxazepam metabolism. Sub-
jects started by consuming a control diet for 10 days, after
which they were put on a diet containing 300g/day of
Brussels sprouts and 200g/day of cabbage over a period of
10 days, and ﬁnally returned to the control diet for the last
10 days. In parallel, every morning the subjects were given
either45mgofoxazepamor1500mgofacetaminophen.The
mean plasma concentrations of either drug were measured
at diﬀerent intervals after administration, and a 24h urinary
recovery of conjugates was performed. Researchers found
that the cruciferous diet enhanced the acetaminophen meta-
bolism and glucuronide conjugation; however, they mention4 Journal of Biomedicine and Biotechnology
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Figure 1: PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) ﬂow diagram of study identiﬁcation, inclusion,
and exclusion.
that the decreased levels of cysteine conjugate in urine actu-
ally indicate reduced toxicity. No changes in oxazepam meta-
bolism were noted [21].
The third safety SCED trial included 10 healthy subjects,
ages 22–40; the goal of this study was to determine the eﬀect
of a diet rich in Brussels sprouts on warfarin metabolism.
Subjects consumed their customary diets for 3 days and were
then instructed to consume 400g/day of Brussels sprouts for
the next 18 days. Warfarin administration (20mg) was pro-
vided twice on days 1 and 18. Mean plasma concentrations
of warfarin were measured at diﬀerent time periods, as well
as prothrombin activity, and clearance rates were calculated.
Researchers showed that the diet had resulted in accelerated
warfarin metabolism and decreased anticoagulation [22].
ThelastsafetySCEDtrialincluded6subjects,ages20–38,
with a history of recurrent allergic reactions to consumption
of raw cabbage.This study aimed to determine the sensitivity
proﬁleofsuchpatientstoothercruciferousvegetables(cauli-
ﬂower, mustard, and broccoli), as well as to cooked versus
raw cabbage. Skin prick tests were performed for a variety of
allergens; later, food challenges were performed with cooked
cabbage, and levels of cabbage-speciﬁc IgE were measured in
patients’ sera. All patients were found to be atopic (5 with
allergic rhinitis); all had positive skin prick tests to mug-
wort (Artemisia vulgaris) pollen and other aeroallergens (for
instance, pollen of plants from the genera Parietaria and
Olea), and 5 had positive skin prick tests to hazelnuts, wal-
nuts, and peanuts. Mustard sensitivity (cross-reactivity with
cabbage) was detected in all patients. Patients demonstrated
no allergic reaction to cooked cabbage. All patients were
found to have cabbage-speciﬁc IgE antibodies in their sera
[23].Journal of Biomedicine and Biotechnology 5
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The nonsafety trials [24–30] included 2 RCTs, 4 con-
trolled clinical trials, and 1 single-case experimental design
trial, of which only one identiﬁed adverse events.
T h et r i a lw h i c hr e p o r t e dt h ea d v e r s ee v e n t sw a sac o n -
trolled clinical trial in 18 subjects, ages 2.5–61, who suﬀered
from recurrent respiratory papillomatosis and underwent
complete surgical removal. All subjects received oral indole-
3-carbinol supplementation for a period of 9–24 months
in order to examine whether the supplements reduced the
occurrence of the papillomas. Doses were 200mg twice a
day for adults, and individually calculated for pediatric pa-
tients based on body weight. Adverse events were reported in
3 patients: 1 adult, who was receiving a higher dose (400mg
twice a day) for 10 days according to the researchers’ recom-
mendation, suﬀered from imbalance and tremor and 2 girls,
2.5 and 12 years old, who took an overdose by mistake, suf-
fered from unsteadiness and nausea. The symptoms in the
adult resolved after returning to original dose and resolved
spontaneously in the girls within a few hours to a day. Accor-
ding to the authors, the supplement did not cause any other
side eﬀects or complications (including acceleration of the
disease) and was generally well tolerated [24]. It is unclear
from this paper which other medications these speciﬁc
individuals were taking, and whether they had any other
acute health conditions which may have contributed to the
adverse events described.
All other non-safety trials reported no adverse events
with oral consumption of broccoli sprout infusion/homo-
genate, mustard oil, cauliﬂower leaves powder or indole-3-
carbinol supplements, or with topical application of broc-
coli sprouts extract [25–30]. These studies included both
adult and pediatric populations, whose concurrent medical
conditionsincludednone(healthy),nutritionaldeﬁcits(hae-
moglobin and retinol), recurrent respiratory papillomatosis,
and acute myocardial infarction (Table 2).
3.3. Observational Studies. Thirteen observational studies
wereincluded,reportingadverseeventsrelatedtocruciferous
plants in 1,247 patients [31–43]. Seven of them were cohort
studies, 3 were case-control studies, 2 were cross-sectional
studies, and 1 was a qualitative survey (Table 3).
Three cohort studies, one case-control study, and one
cross-sectional survey examined prevalence of allergic reac-
tions to oilseed rape [31–35]. In the ﬁrst cohort, 7/1478 sub-
jects who were naturally exposed to oilseed rape had either a
positiveskintest,apositiveradio-allergosorbenttest,ornasal
sensitivity in response to oilseed rape exposure, whereas the
proportion of such allergic reactions was 14/37 in those who
were occupationally exposed to oilseed rape [31].
Inthesecondcohort,only147/4468subjectswithsuspec-
ted oilseed allergy showed positive skin prick test to oilseed
rape; most of the subjects in this study were allergic to a var-
iety of other antigens [32].
In the third cohort, 12/22 village residents reported in-
creased allergic symptoms during a year when oilseed rape
surrounded the village, compared with a year when another
crop surrounded the village. However, authors mention that
the symptoms reported did not correlate with oilseed rape
pollen levels measured. They were therefore not sure what
the true cause could be [33].
Inacase-controlstudy,37peoplecomplainedofseasonal
allergic symptoms and bronchial reactivity in response to an
unknown allergen, of whom 23 were tested. However, only
2 were found to be allergic to oilseed rape and only 10 (in-
cluding those 2) were found to be atopic. The authors con-
cluded that the symptoms could not be attributed to oilseed
rape in most of these cases of seasonal allergy [34].
In the cross-sectional survey, 683/869 of village residents
who were exposed to oilseed rape complained of seasonal
cough, wheeze, and headaches. However, the authors con-
cluded that the proportion of people who suﬀered from such
symptoms was not much higher in subjects living in close
proximity to oilseed rape in comparison to control subjects
whodonot;thissuggeststhattheseasonalsymptomsinrural
areas cannot be attributed to oilseed rape allergy alone [35].
Yet another observational study dealing with allergic
reactionswasacohortin259individualswithsuspectedcon-
tact allergy to foods containing allyl-isothiocyanate. Of 259
subjects who underwent allergy skin tests, 43 had a question-
able reaction, of whom 15 had irritation and 3 had follicular
reaction. Only two showed a true positive reaction, but one
was lost to followup [36].
Three studies suggested a possible connection between
cruciferous vegetables and cancer. The ﬁrst was a cohort
study in 64,327 women in Japan, ages 40–79, which exami-
ned the possible connection between dietary habits and risk
of ovarian cancer death, based on food-frequency question-
naires. Whereas no adverse events were reported with con-
sumption of cabbage or green leafy vegetables, a positive
associationwasestablishedbetweenmoderate-highconsum-
ption of Chinese cabbage and ovarian cancer. The authors
suggestthatthismightbeattributedtothefact,that,inmany
cases, Chinese cabbage is eaten pickled, as pickled food was
proventoincreasetheriskofcancer[37].Theresearchersdid
not adjust for total energy consumption, or for comalignan-
cies such as breast/endometrial cancer; the ﬁrst is important
as several studies found an association between total energy
consumption and increased risk for various types of cancer
[38, 39]. The latter is crucial, as many women with a history
of such comalignancies are at a higher risk of developing
ovarian cancer than the general population [40, 41].
The second suggested a connection between cruciferous
vegetables and cancer in a case-control study from Kuwait in
which 313 thyroid cancer patients were paired with age- and
gender-matched controls; the study’s aim was to examine the
relationshipbetweendiﬀerentsociodemographic,medicalor
dietary factors and thyroid cancer, based on questionnaires.
Whereasnoadverseeventswereassociatedwithbroccolicon-
sumption, a nonstatistically signiﬁcant positive association
was established between moderate-high consumption of
cauliﬂower or cabbage and thyroid cancer (P = 0.08 and P =
0.16, resp.). The authors conclude that no clear association
between consumption of cruciferous vegetables and thyroid
cancer could be established [42].
The last study bringing up a possible association between
cruciferous vegetable consumption and cancer is a case-con-
trol study which paired 246 thyroid cancer patients fromJournal of Biomedicine and Biotechnology 9
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Sweden and Norway with 440 age- and gender-matched con-
trols. The goal of the study was to evaluate the relationship
between certain dietary habits and the risk of follicular and
papillarythyroidcarcinomas.Withregardtocruciferousveg-
etables, researchers found that for people who, at any time,
resided in areas of Sweden where goiter and iodine deﬁciency
were endemic until the 1960’s, there was an increased risk for
thyroid cancer with consumption of cruciferous vegetables.
Theseﬁndings werenotreproducedanywhereelseinSweden
or Norway. Authors suggest that this dual eﬀect might be
related to interactions between cruciferous vegetables and
other food components such as iodine [43]. They also exp-
ressed surprise, as their ﬁndings stood in contradiction to
those of many research groups that found a protective eﬀect
of cruciferous vegetables against thyroid cancer [48–51].
The next observational study included in our paper was
a cross-sectional study which aimed to determine the asso-
ciation between broccoli consumption and chronic atrophic
gastritis in 438 men, ages 39–60 years. The authors found
that consumption of broccoli once or more weekly increased
the risk for chronic atrophic gastritis, based on serological
tests for pepsinogen I and II. However, the authors acknow-
ledge some major drawbacks to their work. First, H. Pylori
infection, which increases the risk for chronic atrophic gas-
tritis, was not measured. Second, serologic criteria were used
for diagnosis, meaning that the results were prone to mea-
surement errors. Moreover, it is unclear whether the changes
in enzyme proﬁles were accompanied by any clinical mani-
festations [46].
Th el a s to b s e rv a ti o n a ls t u d yr e po rti n gad v e r s eev e n t sw a s
a qualitative survey which examined the relationship bet-
ween consumption of certain foods by breast-feeding moth-
ers, and the appearance of colic symptoms in their babies (4
monthsoldoryounger).Thesurveyconductorsfoundapos-
itive association between consumption of cruciferous veg-
etables (cabbage, cauliﬂower, and broccoli) and colic symp-
toms: abdominal pain, irritability, and intense crying [47].
This study exhibited several major limitations: ﬁrst, all deter-
minants of colic symptoms, as deﬁned by the authors (in-
tense crying, irritability, and abdominal pain) can be sub-
jected to subjective interpretation; the diagnosis of infantile
colic, as established over 50 years ago, requires a healthy baby
to exhibit “periods of intense, unexplained fussing/crying
lasting more than 3 hours a day, more than 3 days a week
for more than 3 weeks” [52]. In the study, however, no such
objective temporal requirements were deﬁned; any presen-
tation of the symptoms, regardless of duration, was consid-
eredtoconstitutecolic.Furthermore,sincethequestionnaire
was administered over the course of one week only, instead
of the 3 weeks which are required for diagnosis of colic, it is
doubtful whether such diagnosis can be made at all. More-
over, since food intake and colic symptoms were reported
o n l yf o raw e e k ,i ti sh a r dt oe s t a b l i s hp r o p e rt e m p o r a lr e l a -
tionships between the two.
Two cohort studies included in our paper identiﬁed no
adverse events with exposure to cruciferous plants or their
constituents; the ﬁrst study included 12 subjects who in-
gested 5–7mg/kg/day of indole-3-carbinol [44]. The second
study, which followed 27,111 male smokers over a period of
12 months, attempted to discover whether intakes of fruits,
vegetables, carotenoids, or vitamins A, E, or C could be asso-
ciated with risk of bladder cancer in these people. The study
determined that no association between bladder cancer risk
and chronic consumption of cruciferous vegetables could be
established [45].
3.4. Case Reports. Twenty-four case reports were included in
the review, reporting adverse events in 35 individuals. The
patients ranged from 17 to 70 years of age, whose concurrent
medical conditions included allergies, both to cruciferous
plants and to a variety of other allergens, asthma, bronchitis,
atopy, cardiovascular diseases, and diﬀerent skin conditions
(eczema,pruritus,eryhtema,dermatitis,drynessandscaling,
and blisters) (Table 4). The adverse events occurred after
topical, respiratory, or oral exposure to diﬀerent cruciferous
plants, their constituents, or their derivatives. Twenty-one
case reports reported allergic or hypersensitivity reactions
in 31 individuals, including allergic contact dermatitis/con-
tact urticaria, contact hypersensitivity, aggravation of ecz-
ema, cutaneous lesions similar to pityriasis rosea, asthma,
rhinoconjunctivitis, aggravation of cough and chest pain,
local swelling and itching, and anaphylaxis. The suspected
agents triggering these reactions were turnip seeds, cabbage,
broccoli, oilseed rape (ﬂour or pollen), cauliﬂower, mustard
(a variety of preparation forms), isothiocyanates in paint,
and Diplotaxis erucoides (Brassica erucoides) pollen. It is im-
portant to note that 18 of the individuals (approximately
50%oftotal)hadpreviousriskfactorssuchasatopy,allergies
to allergens unrelated to cruciferous plants (for instance,
grasses,dustmite,nuts),diﬀerentskinconditions,orasthma.
Furthermore, 12 of those people had been exposed to the
allergens occupationally, for chronic periods of time, pre-
sumably leading to the adverse events [53–73].
Two case reports documented warfarin resistance in 3
patients with cardiovascular diseases. The ﬁrst patient had a
prostheticaorticvalveandahistoryofmyocardialinfarctions
with prolonged prothrombin time [74]. The second had pul-
monary embolism, and the third suﬀered from an unspeci-
ﬁed cardiovascular disease [75]. The adverse event in the ﬁrst
patient was attributed to excessive consumption of lettuce
and greens (turnip, mustard greens, broccoli); the patient
was a 35 years old woman who intended to lose weight by
consuming only the above-mentioned foods, which led to a
consumption of 6000µg/day of vitamin K (60 times higher
than the recommended consumption). After 5 weeks of diet-
ing, she felt substernal chest pain and was referred to the
hospital, where a myocardial infarction was diagnosed. She
was treated with heparin and nitroglycerine. The second and
third cases were attributed to chronic consumption of up to
450g/day of broccoli; one of them required treatment with
Coumadin. All three cases ended up in full resolution of
adverse events and a recommendation to restrict consump-
tion of vitamin K-rich foods [74, 75].
The last case report reported a suspected toxic irritative
dermatitis (nonallergic) in an individual who applied a
home-made mustard wrap in order to relieve the symptoms
of bronchitis; authors believe the wrap may have contained
some toxic compounds and concluded that the reaction was14 Journal of Biomedicine and Biotechnology
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n
t
/
s
u
b
s
t
a
n
c
e
R
o
u
t
e
1
D
u
r
a
t
i
o
n
2
D
o
s
e
3
A
d
v
e
r
s
e
e
v
e
n
t
s
A
c
u
t
e
m
a
n
a
g
e
m
e
n
t
O
u
t
c
o
m
e
4
C
a
u
s
a
l
i
t
y
5
C
o
m
m
e
n
t
s
D
i
G
i
a
c
o
m
o
e
t
a
l
.
1
9
9
8
[
5
9
]
4
8
N
o
t
g
i
v
e
n
O
i
l
s
e
e
d
r
a
p
e
ﬂ
o
u
r
R
e
s
p
i
r
a
t
o
r
y
C
h
r
o
n
i
c
(
e
x
a
c
t
d
u
r
a
t
i
o
n
n
o
t
m
e
n
t
i
o
n
e
d
)
N
A
E
p
i
s
o
d
e
s
o
f
a
s
t
h
m
a
a
n
d
r
h
i
n
o
c
o
n
j
u
n
c
t
i
v
i
t
i
s
A
l
l
e
r
g
y
t
e
s
t
s
s
h
o
w
e
d
t
h
a
t
s
k
i
n
p
r
i
c
k
t
e
s
t
s
w
e
r
e
o
n
l
y
m
i
l
d
l
y
p
o
s
i
t
i
v
e
f
o
r
o
i
l
s
e
e
d
r
a
p
e
ﬂ
o
u
r
,
a
n
d
t
h
e
p
e
a
k
r
e
s
p
i
r
a
t
o
r
y
ﬂ
o
w
o
n
l
y
s
l
i
g
h
t
l
y
d
e
c
r
e
a
s
e
d
d
u
r
i
n
g
e
x
p
o
s
u
r
e
N
o
t
m
e
n
t
i
o
n
e
d
N
o
t
m
e
n
t
i
o
n
e
d
P
o
s
s
i
b
l
y
O
c
c
u
p
a
t
i
o
n
a
l
e
x
p
o
s
u
r
e
H
e
r
n
a
n
d
e
z
e
t
a
l
.
2
0
0
5
[
6
0
]
7
0
A
l
l
e
r
g
i
e
s
t
o
s
o
m
e
f
r
u
i
t
a
n
d
n
u
t
s
,
s
e
a
s
o
n
a
l
a
l
l
e
r
g
i
c
r
h
i
n
o
c
o
n
j
u
n
c
t
i
v
i
t
i
s
C
a
u
l
i
ﬂ
o
w
e
r
O
r
a
l
A
c
u
t
e
i
n
g
e
s
t
i
o
n
N
o
t
s
p
e
c
i
ﬁ
e
d
O
r
o
p
h
a
r
y
n
g
e
a
l
i
t
c
h
i
n
g
,
f
a
c
i
a
l
a
n
d
h
a
n
d
s
w
e
l
l
i
n
g
,
s
e
v
e
r
e
b
r
o
n
c
h
o
s
p
a
s
m
R
e
q
u
i
r
e
d
e
m
e
r
g
e
n
c
y
r
o
o
m
c
o
n
s
u
l
t
F
u
l
l
r
e
s
o
l
u
t
i
o
n
P
o
s
s
i
b
l
y
N
o
d
e
t
a
i
l
s
o
f
w
h
a
t
o
t
h
e
r
c
o
m
p
o
n
e
n
t
s
t
h
e
d
i
s
h
i
n
c
l
u
d
e
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C
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R
e
f
e
r
e
n
c
e
P
a
t
i
e
n
t
d
e
t
a
i
l
s
I
n
t
e
r
v
e
n
t
i
o
n
O
u
t
c
o
m
e
A
g
e
C
o
n
c
u
r
r
e
n
t
c
o
n
d
i
t
i
o
n
s
/
t
r
e
a
t
m
e
n
t
s
P
l
a
n
t
/
s
u
b
s
t
a
n
c
e
R
o
u
t
e
1
D
u
r
a
t
i
o
n
2
D
o
s
e
3
A
d
v
e
r
s
e
e
v
e
n
t
s
A
c
u
t
e
m
a
n
a
g
e
m
e
n
t
O
u
t
c
o
m
e
4
C
a
u
s
a
l
i
t
y
5
C
o
m
m
e
n
t
s
J
o
r
r
o
e
t
a
l
.
1
9
9
5
[
6
1
]
4
3
,
1
7
,
a
n
d
1
9
P
a
t
i
e
n
t
1
:
h
i
s
t
o
r
y
o
f
I
g
E
-
d
e
p
e
n
d
e
n
t
r
h
i
n
i
t
i
s
s
i
n
c
e
c
h
i
l
d
h
o
o
d
;
u
r
t
i
c
a
r
i
a
a
n
g
i
o
e
d
e
m
a
e
p
i
s
o
d
e
s
r
e
l
a
t
e
d
w
i
t
h
s
h
e
l
l
ﬁ
s
h
.
P
a
t
i
e
n
t
2
:
h
i
s
t
o
r
y
o
f
I
g
E
-
d
e
p
e
n
d
e
n
t
a
s
t
h
m
a
a
n
d
r
h
i
n
i
t
i
s
a
n
d
u
r
t
i
c
a
r
i
a
t
o
l
a
t
e
x
.
P
a
t
i
e
n
t
3
:
h
i
s
t
o
r
y
o
f
I
g
E
-
d
e
p
e
n
d
e
n
t
r
h
i
n
i
t
i
s
M
u
s
t
a
r
d
s
a
u
c
e
O
r
a
l
A
c
u
t
e
i
n
g
e
s
t
i
o
n
s
N
o
t
s
p
e
c
i
ﬁ
e
d
P
a
t
i
e
n
t
1
:
e
p
i
s
o
d
e
s
o
f
p
r
u
r
i
t
u
s
,
s
w
e
l
l
i
n
g
o
f
t
o
n
g
u
e
,
d
y
s
p
h
a
g
i
a
,
d
y
s
p
h
o
n
i
a
,
f
a
c
i
a
l
e
d
e
m
a
,
a
n
d
p
r
o
g
r
e
s
s
i
v
e
u
p
p
e
r
r
e
s
p
i
r
a
t
o
r
y
d
i
ﬃ
c
u
l
t
y
.
O
n
o
n
e
o
c
c
a
s
i
o
n
,
h
e
e
x
p
e
r
i
e
n
c
e
d
h
y
p
o
t
e
n
s
i
o
n
,
a
n
d
o
n
a
n
o
t
h
e
r
u
r
t
i
c
a
r
i
a
a
n
d
p
a
l
p
e
b
r
a
l
e
d
e
m
a
.
P
a
t
i
e
n
t
2
:
e
p
i
s
o
d
e
s
o
f
p
r
u
r
i
t
u
s
,
s
w
e
l
l
i
n
g
o
f
l
i
p
s
a
n
d
t
o
n
g
u
e
,
a
n
d
e
d
e
m
a
.
P
a
t
i
e
n
t
3
:
d
y
s
p
h
o
n
i
a
,
d
y
s
p
h
a
g
i
a
,
p
r
o
g
r
e
s
s
i
v
e
u
p
p
e
r
r
e
s
p
i
r
a
t
o
r
y
d
i
ﬃ
c
u
l
t
y
,
a
n
d
g
e
n
e
r
a
l
i
z
e
d
u
r
t
i
c
a
r
i
a
.
U
p
o
n
a
l
l
e
r
g
y
t
e
s
t
i
n
g
,
p
a
t
i
e
n
t
s
w
e
r
e
f
o
u
n
d
t
o
b
e
a
l
l
e
r
g
i
c
t
o
m
u
s
t
a
r
d
N
o
t
m
e
n
t
i
o
n
e
d
F
u
l
l
r
e
s
o
l
u
t
i
o
n
L
i
k
e
l
y
N
o
n
e
L
i
n
g
e
l
b
a
c
h
e
t
a
l
.
2
0
0
3
[
6
2
]
4
0
F
o
r
t
h
e
p
a
s
t
1
1
y
e
a
r
s
:
e
p
i
s
o
d
e
s
o
f
e
x
e
r
c
i
s
e
-
i
n
d
u
c
e
d
a
n
a
p
h
y
l
a
x
i
s
a
f
t
e
r
e
a
t
i
n
g
,
o
n
c
e
o
r
t
w
i
c
e
a
y
e
a
r
C
a
b
b
a
g
e
a
n
d
m
u
s
t
a
r
d
O
r
a
l
A
c
u
t
e
i
n
g
e
s
t
i
o
n
s
N
A
A
n
a
p
h
y
l
a
x
i
s
i
n
d
u
c
e
d
b
y
e
x
e
r
c
i
s
e
a
f
t
e
r
i
n
g
e
s
t
i
o
n
o
f
c
a
b
b
a
g
e
o
r
m
u
s
t
a
r
d
I
V
a
d
r
e
n
a
l
i
n
e
,
a
n
t
i
h
i
s
t
a
m
i
n
e
,
a
n
d
c
o
r
t
i
c
o
s
t
e
r
o
i
d
s
F
u
l
l
r
e
s
o
l
u
t
i
o
n
L
i
k
e
l
y
P
a
t
i
e
n
t
w
a
s
a
l
s
o
f
o
u
n
d
t
o
b
e
a
l
l
e
r
g
i
c
t
o
o
t
h
e
r
f
o
o
d
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R
e
f
e
r
e
n
c
e
P
a
t
i
e
n
t
d
e
t
a
i
l
s
I
n
t
e
r
v
e
n
t
i
o
n
O
u
t
c
o
m
e
A
g
e
C
o
n
c
u
r
r
e
n
t
c
o
n
d
i
t
i
o
n
s
/
t
r
e
a
t
m
e
n
t
s
P
l
a
n
t
/
s
u
b
s
t
a
n
c
e
R
o
u
t
e
1
D
u
r
a
t
i
o
n
2
D
o
s
e
3
A
d
v
e
r
s
e
e
v
e
n
t
s
A
c
u
t
e
m
a
n
a
g
e
m
e
n
t
O
u
t
c
o
m
e
4
C
a
u
s
a
l
i
t
y
5
C
o
m
m
e
n
t
s
M
e
d
i
n
g
1
9
8
5
[
6
3
]
4
0
V
e
s
i
c
u
l
a
r
h
a
n
d
e
c
z
e
m
a
f
o
r
t
h
e
p
a
s
t
9
y
e
a
r
s
,
s
o
m
e
t
i
m
e
s
w
o
r
s
e
n
e
d
f
o
r
n
o
c
l
e
a
r
r
e
a
s
o
n
,
a
n
d
a
l
s
o
a
f
t
e
r
e
v
e
r
y
m
u
s
t
a
r
d
i
n
g
e
s
t
i
o
n
M
u
s
t
a
r
d
a
n
d
r
a
p
e
s
e
e
d
O
r
a
l
(
h
o
w
e
v
e
r
,
a
l
l
e
r
g
y
t
e
s
t
i
n
g
w
a
s
t
o
p
i
c
a
l
)
A
c
u
t
e
i
n
g
e
s
t
i
o
n
s
N
o
t
s
p
e
c
i
ﬁ
e
d
V
e
s
i
c
u
l
a
r
e
p
i
s
o
d
e
s
(
w
o
r
s
e
n
i
n
g
o
f
e
c
z
e
m
a
)
.
P
o
s
i
t
i
v
e
s
k
i
n
p
r
i
c
k
t
e
s
t
t
o
c
r
u
s
h
e
d
s
e
e
d
s
o
f
r
a
p
e
s
e
e
d
N
o
t
m
e
n
t
i
o
n
e
d
P
a
r
t
i
a
l
r
e
s
o
l
u
t
i
o
n
:
e
c
z
e
m
a
i
m
p
r
o
v
e
d
u
p
o
n
a
v
o
i
d
a
n
c
e
o
f
m
u
s
t
a
r
d
a
n
d
r
a
p
e
s
e
e
d
P
o
s
s
i
b
l
y
A
p
a
r
t
f
r
o
m
i
n
g
e
s
t
i
o
n
,
p
a
t
i
e
n
t
w
a
s
a
l
s
o
o
c
c
u
p
a
-
t
i
o
n
a
l
l
y
e
x
p
o
s
e
d
t
o
r
a
p
e
s
e
e
dJournal of Biomedicine and Biotechnology 19
T
a
b
l
e
4
:
C
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n
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R
e
f
e
r
e
n
c
e
P
a
t
i
e
n
t
d
e
t
a
i
l
s
I
n
t
e
r
v
e
n
t
i
o
n
O
u
t
c
o
m
e
A
g
e
C
o
n
c
u
r
r
e
n
t
c
o
n
d
i
t
i
o
n
s
/
t
r
e
a
t
m
e
n
t
s
P
l
a
n
t
/
s
u
b
s
t
a
n
c
e
R
o
u
t
e
1
D
u
r
a
t
i
o
n
2
D
o
s
e
3
A
d
v
e
r
s
e
e
v
e
n
t
s
A
c
u
t
e
m
a
n
a
g
e
m
e
n
t
O
u
t
c
o
m
e
4
C
a
u
s
a
l
i
t
y
5
C
o
m
m
e
n
t
s
P
a
s
r
i
c
h
a
e
t
a
l
.
1
9
8
5
[
6
4
]
3
5
a
n
d
4
7
P
a
t
i
e
n
t
1
h
a
d
s
u
ﬀ
e
r
e
d
f
r
o
m
d
e
r
m
a
t
i
t
i
s
e
v
e
r
s
i
n
c
e
s
h
e
w
a
s
1
5
,
w
h
i
c
h
w
o
r
s
e
n
e
d
w
h
e
n
h
a
n
d
l
i
n
g
c
a
t
t
l
e
f
o
o
d
.
P
a
t
i
e
n
t
2
:
i
t
c
h
i
n
g
a
n
d
e
r
y
t
h
e
m
a
t
o
u
s
p
a
p
u
l
e
s
f
o
r
t
h
e
p
a
s
t
1
.
5
y
e
a
r
s
,
f
o
r
w
h
i
c
h
s
h
e
w
a
s
t
r
e
a
t
e
d
P
a
t
i
e
n
t
1
:
m
u
s
t
a
r
d
;
P
a
t
i
e
n
t
2
:
m
u
s
t
a
r
d
k
h
a
l
T
o
p
i
c
a
l
C
h
r
o
n
i
c
(
e
x
a
c
t
d
u
r
a
t
i
o
n
n
o
t
m
e
n
t
i
o
n
e
d
)
N
A
P
a
t
i
e
n
t
1
:
i
t
c
h
i
n
g
a
n
d
e
r
y
t
h
m
a
t
o
u
s
p
a
p
u
l
a
r
l
e
s
i
o
n
s
o
n
f
o
r
e
a
r
m
s
,
a
r
m
s
,
n
e
c
k
,
f
o
r
e
h
e
a
d
,
e
a
r
l
o
b
u
l
e
s
,
a
n
d
s
i
d
e
s
o
f
f
a
c
e
f
o
r
t
h
e
p
a
s
t
8
m
o
n
t
h
s
.
P
a
t
i
e
n
t
2
:
i
t
c
h
i
n
g
a
n
d
e
r
y
t
h
m
a
t
o
u
s
p
a
p
u
l
e
s
o
n
f
o
r
e
a
r
m
s
,
f
o
r
e
h
e
a
d
,
c
h
e
e
k
s
,
e
a
r
l
o
b
u
l
e
s
,
n
e
c
k
,
a
n
d
d
o
r
s
u
m
o
f
f
e
e
t
f
o
r
t
h
e
p
a
s
t
1
.
5
y
e
a
r
s
.
U
p
o
n
a
l
l
e
r
g
y
t
e
s
t
i
n
g
,
p
a
t
i
e
n
t
1
f
o
u
n
d
t
o
b
e
a
l
l
e
r
g
i
c
t
o
m
u
s
t
a
r
d
,
j
o
w
a
r
ﬂ
o
u
r
,
a
n
d
w
h
e
a
t
ﬂ
o
u
r
.
P
a
t
i
e
n
t
2
f
o
u
n
d
t
o
b
e
a
l
l
e
r
g
i
c
t
o
m
u
s
t
a
r
d
k
h
a
l
a
n
d
m
a
i
z
e
N
o
t
m
e
n
t
i
o
n
e
d
(
i
t
i
s
m
e
n
t
i
o
n
e
d
t
h
a
t
t
r
e
a
t
m
e
n
t
w
a
s
g
i
v
e
n
,
b
u
t
n
o
f
u
r
t
h
e
r
d
e
t
a
i
l
s
a
r
e
p
r
o
v
i
d
e
d
)
I
m
p
r
o
v
e
d
w
i
t
h
t
r
e
a
t
m
e
n
t
,
b
u
t
a
u
t
h
o
r
s
d
o
n
o
t
m
e
n
t
i
o
n
w
h
a
t
h
a
p
p
e
n
s
w
h
e
n
n
o
t
e
x
p
o
s
e
d
P
o
s
s
i
b
l
y
(
p
a
t
i
e
n
t
1
)
,
u
n
l
i
k
e
l
y
(
p
a
t
i
e
n
t
2
)
P
a
t
i
e
n
t
1
h
a
d
b
e
e
n
u
s
i
n
g
m
u
s
t
a
r
d
o
i
l
f
o
r
y
e
a
r
s
a
n
d
o
n
l
y
l
a
t
e
l
y
d
i
d
s
h
e
s
t
a
r
t
e
x
p
e
r
i
e
n
c
i
n
g
a
d
v
e
r
s
e
e
v
e
n
t
.
P
a
t
i
e
n
t
2
d
i
d
n
o
t
r
e
p
o
r
t
a
n
y
e
x
p
o
s
u
r
e
t
o
m
u
s
t
a
r
d
Q
u
i
r
c
e
e
t
a
l
.
2
0
0
5
[
6
5
]
4
1
A
l
l
e
r
g
i
c
r
h
i
n
o
c
o
n
j
u
n
c
t
i
v
i
t
i
s
t
o
p
o
l
l
e
n
.
F
o
r
p
a
s
t
7
y
e
a
r
s
:
e
p
i
s
o
d
e
s
o
f
o
c
u
l
a
r
a
n
d
n
a
s
a
l
i
t
c
h
i
n
g
,
s
n
e
e
z
i
n
g
,
w
a
t
e
r
y
n
o
s
e
,
t
e
a
r
i
n
g
,
d
r
y
c
o
u
g
h
,
c
h
e
s
t
t
i
g
h
t
n
e
s
s
,
a
n
d
d
y
s
p
n
e
a
a
f
t
e
r
i
n
h
a
l
i
n
g
c
a
u
l
i
ﬂ
o
w
e
r
o
r
c
a
b
b
a
g
e
v
a
p
o
r
s
C
a
b
b
a
g
e
O
r
a
l
A
c
u
t
e
i
n
g
e
s
t
i
o
n
N
o
t
s
p
e
c
i
ﬁ
e
d
G
e
n
e
r
a
l
i
z
e
d
u
r
t
i
c
a
r
i
a
,
f
a
c
i
a
l
a
n
d
o
r
o
p
h
a
r
y
n
g
e
a
l
a
n
g
i
o
e
d
e
m
a
.
U
p
o
n
a
l
l
e
r
g
y
t
e
s
t
i
n
g
(
w
i
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not an allergic one. Hence, they advised against the use of
home-made wraps. The patient was treated with corticoste-
roids with full resolution. This case was very brief and lacked
a great deal of information regarding previous medical his-
tory and whether other medications had been used to treat
the patient’s bronchitis. Moreover, no test was conducted to
verify the cause of the adverse event [76].
3.5. Excluded Papers. Of the 317 papers excluded, 280 did
not fulﬁll the criteria for our systematic review (i.e., they did
not evaluate adverse eﬀects or lack thereof, intervention or
substance exposure did not include cruciferous plants, or did
not present original data). Another 37 articles were exclu-
ded since they dealt with toxic oil syndrome. In order to pro-
mote transparency in our decision-making process, we shall
explain the rationale behind excluding this latter group of
papers.
Toxic oil syndrome is the name given to a disease out-
break in Spain in 1981. Its ﬁrst appearance was as an acute
lung disease, which was followed by a range of other chronic
symptoms aﬀecting the lungs, the liver, the kidneys, the skin,
the joints, the central nervous system, and the immune sys-
tem [77–83]. The cause for the disease was traced to the
consumption of cheap, reﬁned, rapeseed oil that had been
intended for industrial use rather than for human consump-
tion. It was sold as “olive oil” and was therefore used for
cooking. According to the World Health Organization, toxic
compounds derived during the reﬁnement process, used to
remove the aniline and to denature oils intended for indus-
trial use, were responsible for causing the disease. Hence,
toxic oil syndrome has come to be considered a chemical
incident, rather than a side eﬀect associated with consump-
tion of rapeseed oil, since consumption of non-industrial
rapeseed oil does not cause the disease. In fact, the speciﬁc
reﬁnement process of the oil that caused the disease was so
unique that experimental studies performed in a variety of
laboratory animals have hitherto failed to reproduce the
symptoms of human toxic oil syndrome [84].
4. Discussion
Research conducted in the last decade supports the notion
that some cruciferous plants and their derivatives may serve
topreventorattenuateseveralmedicalconditions.Tofurther
thisﬁeldofinvestigation,weconductedthissystematicpaper
to determine the safety parameters surrounding the use
of cruciferous plants. In this regard, our review identiﬁed
adverse events in 1335 individuals, out of a total of 101,198
individuals who were included in all studies. Of these, 1292
adverse events were ranked as only possibly or unlikely to
be caused by cruciferous plants. Only 43 were determined to
have been certainly or likely caused by exposure to crucifer-
ous plants. Adverse events, which could certainly or likely be
attributedtomembersoftheBrassicagenus,includedallergic
reactions (including anaphylaxis), changes in metabolism of
acetaminophen,phenacetinandwarfarin,andwarfarinresis-
tance. Most adverse events reported in our paper were aller-
gic or hypersensitivity reactions; however, their signiﬁcance
for the general healthy population is hard to infer, due to
confounding medical histories or low causality ratings. Ad-
verse events from both allergy trials and case reports were
mostly in individuals who suﬀered from atopy, allergies to
cruciferous plants and/or other allergens (for instance, gras-
ses, ragweed, dust mite, pollen, dogs, cats and diﬀerent fruit
and nuts), asthma, or a variety of skin conditions such as
eczema, pruritus, erythema, dermatitis, dryness and scaling,
or blisters. A possible conclusion from these case reports,
however,isthatoccupationalexposuretoBrassicaplantsmay
predispose to develop an allergy to these plants. With regards
to observational studies which investigated allergies to cruci-
ferous plants or their derivatives, all concluded that the cases
could not be attributed to the suspected culprits.
A second category of adverse events included changes in
metabolism of phenacetin, acetaminophen, and warfarin.
WhilephenacetinhasbeenbannedforusebytheFDA,aceta-
minophen and warfarin continue to be widely used. As such,
it was important to understand if these changes in meta-
bolism pose any risk to those who use these drugs. As for
acetaminophen, the authors explain that the decreased levels
of the cysteine conjugate of acetaminophen found in sub-
jects’ urine actually indicate decreased toxicity; thus, cru-
ciferous plants may not pose any risk to individuals who
consumeacetaminophen.Withregardstowarfarin,however,
the ﬁnding that cruciferous vegetables alter its metabolism
might bear greater clinical relevance. It has been suggested
that foods high in vitamin K, such as cruciferous vegetables,
may interact with warfarin and its anticoagulant activity. In
all case reports describing warfarin resistance, the patients
had consumed very large amounts of cruciferous vegetables
(up to 450g/day or the equivalent of 6000µg vitamin K/day),
amounts not warranted for consumption by the general
population. However, it is possible that lower doses would
have some eﬀects on anticoagulation as well. Similarly large
amounts of cruciferous vegetables (400g/day) were given to
subjects in the SCED trial which examined changes in war-
farin resistance. As many foods interact with warfarin,
among which are mango, avocado, ﬁsh oil, soy milk, and
foods high in vitamin K [84], it is imperative for physicians
to discuss the consumption of such foods (including crucif-
erous vegetables) with their patients when starting treatment
with anticoagulants.
Reports of other types of adverse events identiﬁed in our
systematic review, including cancer, chronic atrophic gas-
tritis, infantile colic, and toxicity-related events, could only
be ranked as possibly or unlikely to be caused by exposure
to cruciferous plants, as there was not enough evidence to
establish a stronger causal relationship between the suspec-
ted culprits and the adverse events. Further research employ-
ing better methodology should be undertaken in order to
establish whether positive association exists between con-
sumption of Brassica vegetables and any of the above-men-
tioned adverse events.
Finally, a number of studies did not ﬁnd any adverse
events associated with consumption of cruciferous plants or
their derivatives in subjects with a variety of health condi-
tions, including history of myocardial infarction, nutritional
deﬁcits,orrecurrentrespiratorypapillomatosis,orinhealthy
individuals.Journal of Biomedicine and Biotechnology 25
In summary, to date, adverse events presumably related
to cruciferous plants have been reported in 1335 individuals,
identiﬁed through 50 studies which included a total of
101,198 individuals. However, the number of those which
were certainly/likely caused by Brassica plants (including
allergic reactions, changes in drug metabolism, and warfarin
resistance) was much lower: only 43 of all reported adverse
events received such high causality rating. For comparison,
the literature shows that the pooled prevalence of adverse
drug reactions ranges from 4.2 to 6% [85]. This frequency,
if applied to cruciferous plants, would translate into 4250–
6072 reports of adverse events out of the included 101,198
individuals, a value much higher than what was found in our
current study.
When analysing our ﬁndings, one must bear in mind
that the total number of individuals included in all studies
comprisesboththosewhoweredeﬁnitelyexposedtoBrassica
plants and those who were presumptively exposed as the
degree of exposure could not be ascertained in all cases. This
might cause the frequency of occurrence of adverse events
to appear lower than the actual value. On the other hand,
our study also included case reports of individuals, all of
whom were exposed, and reported adverse events. In this
regard, the frequency of adverse events tends to be an over-
estimation, since individuals who are exposed, but do not
experience an adverse event, are likely not to report. Hence,
the inclusion of these case report, in which essentially all
individuals exposed report adverse events, may serve to
balance this underestimation. We advise the reader to treat
the broad pooled frequency presented in the previous para-
graph (1335/101,198) as merely gross estimations of the
actual frequency, as conducting a meta-analysis per se was
deemed inappropriate given the heterogeneity of study para-
meters (subjects, interventions, clinical outcomes, and study
designs).
We conclude that cruciferous plants are generally safe for
human consumption and use. However, individuals with
known allergies/hypersensitivities to a certain member of the
Brassica genus, or those taking warfarin, should consult with
their physician before consuming such vegetables. In the fu-
ture,ifcruciferousderivativesaretobeinvestigatedaspoten-
tial therapeutic agents, we recommend that adverse events
be monitored. As our ﬁndings reﬂect positively on the safety
of Brassica plants in humans and evidence from the current
experimental literature of their beneﬁt in certain disease
states, we would encourage further exploration of their po-
tential use in the clinical setting. The use of brassica or simi-
lar food products may have the potential to provide a safer
alternative for the treatment of disease in comparison to cur-
rent pharmaceutical interventions.
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